Controversies in implementing non-invasive prenatal testing in a public antenatal care program.

Area of Science:

• Biotechnology
• Genetics
• Public Health

Background:

• Norway's 2020 Biotechnology Act permits first-trimester screening for common trisomies using cell-free DNA for all pregnant women.
• Implementation of non-invasive prenatal testing (NIPT) in public antenatal care faces challenges due to varying perceptions of trisomy 21 severity and ethical considerations.
• The equitable provision of NIPT services is complicated by the involvement of private institutions and public hospitals, impacting quality and access.

Purpose of the Study:

• To explore the challenges and ethical considerations of implementing non-invasive prenatal testing (NIPT) within Norway's public antenatal care system.
• To examine the implications of offering universal NIPT, including potential increases in pregnancy terminations and the need for robust genetic counseling.
• To address the complexities of integrating private and public healthcare sectors for NIPT service delivery to ensure equitable access.

Main Methods:

• Review of the Norwegian Biotechnology Act (2020) and its implications for prenatal screening.
• Analysis of ethical debates surrounding trisomy screening, pregnancy termination, and cost-benefit assessments.
• Examination of logistical and organizational challenges in providing NIPT through a mixed public-private healthcare model.

Main Results:

• The integration of NIPT into Norway's public healthcare system is hindered by differing views on trisomy 21 and ethical dilemmas concerning pregnancy terminations.
• Offering NIPT universally raises concerns about cost-effectiveness, particularly for younger populations with lower trisomy prevalence.
• Effective genetic pre-test counseling and clear guidelines for service organization are crucial for quality and equitable access.

Conclusions:

• Implementing universal NIPT in Norway requires careful consideration of ethical, societal, and logistical factors.
• Enhanced genetic counseling and a well-defined framework for public-private collaboration are essential for successful NIPT integration.
• Addressing diverse perspectives on trisomy 21 and ensuring equitable access remain key challenges for Norway's prenatal screening program.